Amyloid-beta precursor protein (P05067)

Uniprot ID P05067
Protein Name Amyloid-beta precursor protein
Gene Name APP
Species Homo sapiens (Human)
Signal peptide(a) N Secretome P(b) 0.237
Function Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed:25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(O) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapes in axons (PubMed:17062754, PubMed:23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1. .Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more effective reductant than amyloid-beta protein 40. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. APP42-beta may activate mononuclear phagocytes in the brain and elicit inflammatory responses. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain. {ECO:0000250}.The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6).
GO - Molecular function
  • acetylcholine receptor activator activity : TAS:ARUK-UCL
  • acetylcholine receptor binding : IPI:UniProtKB
  • amylin binding : TAS:ARUK-UCL
  • apolipoprotein binding : IPI:ARUK-UCL
  • chaperone binding : IPI:ARUK-UCL
  • chemoattractant activity : IGI:ARUK-UCL
  • DNA binding : ISS:UniProtKB
  • enzyme binding : IPI:ParkinsonsUK-UCL
  • ephrin receptor binding : IPI:ARUK-UCL
  • frizzled binding : IPI:ARUK-UCL
  • G protein-coupled receptor binding : IPI:ARUK-UCL
  • growth factor receptor binding : IEA:Ensembl
  • heparan sulfate binding : TAS:ARUK-UCL
  • heparan sulfate proteoglycan binding : IMP:ARUK-UCL
  • heparin binding : IEA:UniProtKB-KW
  • identical protein binding : IPI:IntAct
  • insulin receptor binding : IPI:ARUK-UCL
  • integrin binding : IDA:ARUK-UCL
  • low-density lipoprotein particle receptor binding : ISS:ARUK-UCL
  • peptidase activator activity : IEA:Ensembl
  • protein dimerization activity : IDA:ARUK-UCL
  • protein heterodimerization activity : IPI:ARUK-UCL
  • protein homodimerization activity : IDA:ARUK-UCL
  • PTB domain binding : IPI:BHF-UCL
  • RAGE receptor binding : IPI:ARUK-UCL
  • RNA polymerase II cis-regulatory region sequence-specific DNA binding : IEA:Ensembl
  • RNA polymerase II core promoter sequence-specific DNA binding : IGI:ARUK-UCL
  • serine-type endopeptidase inhibitor activity : IDA:UniProtKB
  • signaling receptor activator activity : IDA:ARUK-UCL
  • signaling receptor binding : IPI:ARUK-UCL
  • transition metal ion binding : IEA:InterPro
GO - Biological process
  • activation of MAPK activity : ISS:ARUK-UCL
  • activation of MAPKKK activity : IGI:ARUK-UCL
  • adenylate cyclase-activating G protein-coupled receptor signaling pathway : IGI:ARUK-UCL
  • adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway : IGI:ARUK-UCL
  • adult locomotory behavior : ISS:UniProtKB
  • amyloid fibril formation : IMP:ParkinsonsUK-UCL
  • antibacterial humoral response : IDA:UniProtKB
  • antifungal humoral response : IMP:UniProtKB
  • antimicrobial humoral immune response mediated by antimicrobial peptide : IMP:UniProtKB
  • associative learning : IGI:ARUK-UCL
  • astrocyte activation : IGI:ARUK-UCL
  • astrocyte activation involved in immune response : IGI:ARUK-UCL
  • axo-dendritic transport : ISS:UniProtKB
  • axon midline choice point recognition : ISS:UniProtKB
  • axonogenesis : ISS:UniProtKB
  • calcium-mediated signaling : IDA:ARUK-UCL
  • cell adhesion : IEA:UniProtKB-KW
  • cellular copper ion homeostasis : ISS:UniProtKB
  • cellular process : IMP:ParkinsonsUK-UCL
  • cellular protein metabolic process : TAS:Reactome
  • cellular response to amyloid-beta : IGI:ARUK-UCL
  • cellular response to cAMP : IEA:Ensembl
  • cellular response to copper ion : IEA:Ensembl
  • cellular response to manganese ion : IEA:Ensembl
  • cellular response to nerve growth factor stimulus : IEA:Ensembl
  • cellular response to norepinephrine stimulus : IEA:Ensembl
  • cholesterol metabolic process : IEA:Ensembl
  • cognition : ISS:UniProtKB
  • collateral sprouting in absence of injury : ISS:UniProtKB
  • defense response to Gram-negative bacterium : IDA:UniProtKB
  • defense response to Gram-positive bacterium : IDA:UniProtKB
  • dendrite development : ISS:UniProtKB
  • endocytosis : ISS:UniProtKB
  • extracellular matrix organization : ISS:UniProtKB
  • forebrain development : IEA:Ensembl
  • G protein-coupled receptor signaling pathway : IDA:ARUK-UCL
  • innate immune response : IMP:UniProtKB
  • ionotropic glutamate receptor signaling pathway : ISS:UniProtKB
  • learning : IMP:ARUK-UCL
  • learning or memory : IMP:ARUK-UCL
  • lipoprotein metabolic process : IC:ARUK-UCL
  • locomotory behavior : ISS:UniProtKB
  • mating behavior : ISS:UniProtKB
  • memory : IGI:ARUK-UCL
  • microglia development : IGI:ARUK-UCL
  • microglial cell activation : IGI:ARUK-UCL
  • modulation of age-related behavioral decline : IMP:ARUK-UCL
  • modulation of excitatory postsynaptic potential : IGI:ARUK-UCL
  • mRNA polyadenylation : ISS:UniProtKB
  • negative regulation of blood circulation : IGI:ARUK-UCL
  • negative regulation of canonical Wnt signaling pathway : IDA:ARUK-UCL
  • negative regulation of cell population proliferation : IDA:UniProtKB
  • negative regulation of gene expression : IDA:ARUK-UCL
  • negative regulation of long-term synaptic potentiation : IGI:ARUK-UCL
  • negative regulation of mitochondrion organization : TAS:ARUK-UCL
  • negative regulation of neuron death : IDA:ARUK-UCL
  • negative regulation of neuron differentiation : IEA:Ensembl
  • negative regulation of pri-miRNA transcription by RNA polymerase II : IDA:ARUK-UCL
  • negative regulation of protein localization to nucleus : IGI:ARUK-UCL
  • negative regulation of transcription by RNA polymerase II : IGI:ARUK-UCL
  • neuromuscular process controlling balance : IEA:Ensembl
  • neuron apoptotic process : IMP:UniProtKB
  • neuron projection development : ISS:UniProtKB
  • neuron projection maintenance : IGI:ARUK-UCL
  • neuron remodeling : ISS:UniProtKB
  • Notch signaling pathway : IEA:UniProtKB-KW
  • platelet degranulation : TAS:Reactome
  • positive regulation of 1-phosphatidylinositol-3-kinase activity : IGI:ARUK-UCL
  • positive regulation of amyloid fibril formation : IMP:ARUK-UCL
  • positive regulation of amyloid-beta formation : IGI:ARUK-UCL
  • positive regulation of apoptotic process : IDA:ARUK-UCL
  • positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process : IGI:ARUK-UCL
  • positive regulation of cell activation : NAS:ARUK-UCL
  • positive regulation of cellular response to thapsigargin : IDA:ARUK-UCL
  • positive regulation of cellular response to tunicamycin : IDA:ARUK-UCL
  • positive regulation of chemokine biosynthetic process : IGI:ARUK-UCL
  • positive regulation of cysteine-type endopeptidase activity involved in apoptotic process : IDA:ARUK-UCL
  • positive regulation of cytosolic calcium ion concentration : NAS:ARUK-UCL
  • positive regulation of DNA-binding transcription factor activity : IGI:ARUK-UCL
  • positive regulation of endothelin secretion : IGI:ARUK-UCL
  • positive regulation of ERK1 and ERK2 cascade : IGI:ARUK-UCL
  • positive regulation of excitatory postsynaptic potential : IGI:ARUK-UCL
  • positive regulation of G protein-coupled receptor internalization : IDA:ARUK-UCL
  • positive regulation of G protein-coupled receptor signaling pathway : IDA:ARUK-UCL
  • positive regulation of G2/M transition of mitotic cell cycle : IEA:Ensembl
  • positive regulation of gene expression : IDA:ARUK-UCL
  • positive regulation of glycolytic process : IGI:ARUK-UCL
  • positive regulation of histone acetylation : IGI:ARUK-UCL
  • positive regulation of interferon-gamma secretion : IGI:ARUK-UCL
  • positive regulation of interleukin-1 beta biosynthetic process : IGI:ARUK-UCL
  • positive regulation of interleukin-6 biosynthetic process : IGI:ARUK-UCL
  • positive regulation of JNK cascade : IGI:ARUK-UCL
  • positive regulation of long-term synaptic potentiation : IGI:ARUK-UCL
  • positive regulation of MAPK cascade : IGI:ARUK-UCL
  • positive regulation of membrane protein ectodomain proteolysis : IDA:ARUK-UCL
  • positive regulation of mitotic cell cycle : ISS:UniProtKB
  • positive regulation of monocyte chemotaxis : IDA:ARUK-UCL
  • positive regulation of neuron apoptotic process : IDA:ARUK-UCL
  • positive regulation of neuron death : IDA:ARUK-UCL
  • positive regulation of neuron differentiation : IGI:ARUK-UCL
  • positive regulation of NF-kappaB transcription factor activity : IGI:ARUK-UCL
  • positive regulation of NIK/NF-kappaB signaling : IDA:ARUK-UCL
  • positive regulation of nitric oxide biosynthetic process : IGI:ARUK-UCL
  • positive regulation of oxidative stress-induced neuron death : IGI:ARUK-UCL
  • positive regulation of peptidyl-serine phosphorylation : IMP:ARUK-UCL
  • positive regulation of peptidyl-threonine phosphorylation : IMP:ARUK-UCL
  • positive regulation of phosphorylation : IGI:ARUK-UCL
  • positive regulation of protein binding : IDA:ARUK-UCL
  • positive regulation of protein import : IDA:ARUK-UCL
  • positive regulation of protein kinase A signaling : NAS:ARUK-UCL
  • positive regulation of protein kinase B signaling : NAS:ARUK-UCL
  • positive regulation of protein metabolic process : IMP:ARUK-UCL
  • positive regulation of protein phosphorylation : IDA:ARUK-UCL
  • positive regulation of protein tyrosine kinase activity : IGI:ARUK-UCL
  • positive regulation of receptor binding : IDA:ARUK-UCL
  • positive regulation of response to endoplasmic reticulum stress : IDA:ARUK-UCL
  • positive regulation of superoxide anion generation : IGI:ARUK-UCL
  • positive regulation of T cell migration : IMP:ARUK-UCL
  • positive regulation of tau-protein kinase activity : IGI:ARUK-UCL
  • positive regulation of transcription by RNA polymerase II : IGI:ARUK-UCL
  • positive regulation of tumor necrosis factor biosynthetic process : IGI:ARUK-UCL
  • post-translational protein modification : TAS:Reactome
  • protein homooligomerization : IDA:ARUK-UCL
  • protein phosphorylation : ISS:UniProtKB
  • protein tetramerization : IMP:ARUK-UCL
  • protein trimerization : IMP:ARUK-UCL
  • regulation of acetylcholine-gated cation channel activity : IGI:ARUK-UCL
  • regulation of amyloid fibril formation : IGI:ARUK-UCL
  • regulation of amyloid-beta clearance : IC:ARUK-UCL
  • regulation of dendritic spine maintenance : IGI:ARUK-UCL
  • regulation of epidermal growth factor-activated receptor activity : ISS:UniProtKB
  • regulation of gene expression : IGI:ARUK-UCL
  • regulation of long-term neuronal synaptic plasticity : IGI:ARUK-UCL
  • regulation of multicellular organism growth : ISS:UniProtKB
  • regulation of NMDA receptor activity : TAS:ARUK-UCL
  • regulation of peptidyl-tyrosine phosphorylation : IGI:ARUK-UCL
  • regulation of presynapse assembly : IDA:SynGO
  • regulation of response to calcium ion : ISS:ARUK-UCL
  • regulation of spontaneous synaptic transmission : IGI:ARUK-UCL
  • regulation of synapse structure or activity : ISS:UniProtKB
  • regulation of toll-like receptor signaling pathway : IGI:ARUK-UCL
  • regulation of transcription by RNA polymerase II : IGI:ARUK-UCL
  • regulation of translation : ISS:UniProtKB
  • regulation of Wnt signaling pathway : IC:ARUK-UCL
  • response to interleukin-1 : ISS:ARUK-UCL
  • response to lead ion : IEA:Ensembl
  • response to oxidative stress : IEA:Ensembl
  • response to yeast : IMP:UniProtKB
  • smooth endoplasmic reticulum calcium ion homeostasis : IEA:Ensembl
  • suckling behavior : IEA:Ensembl
  • synapse organization : IGI:ARUK-UCL
  • synaptic growth at neuromuscular junction : IEA:Ensembl
  • tumor necrosis factor production : IGI:ARUK-UCL
  • visual learning : ISS:UniProtKB
Back
(a) The Signal peptide D-score cutoff for "YES"(having signal peptide) is 0.45.
(b) Non-classically secreted proteins should obtain an NN-score(Neural Networks score) exceeding the normal threshold of 0.5, but not at the same time be predicted to contain a signal peptide.